A.R.T. Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
A.R.T. Advisors's EW Position: Q2 2018 in Review
A.R.T. Advisors sold out of Edwards Lifesciences (EW) in Q2 2018, closing a stake of 121,800 shares — an estimated $5.66M sold.
A.R.T. Advisors first reported a position in EW in Q3 2013 and held it in 14 quarters. The position peaked at $11.9M in Q2 2015. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.
- A.R.T. Advisors reported no remaining Edwards Lifesciences position as of Q2 2018 after selling out during the quarter.
- A.R.T. Advisors sold 121,800 Edwards Lifesciences shares in Q2 2018, an estimated $5.66M.
- A.R.T. Advisors first reported a position in Edwards Lifesciences in Q3 2013 and held it in 14 quarters.
- A.R.T. Advisors's Edwards Lifesciences position peaked at $11.9M in Q2 2015.
- 838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.
Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.